Extended interval dosing of natalizumab in multiple sclerosis. Zhovtis Ryerson L, Frohman TC, Foley J, Kister I, Weinstock-Guttman B, Tornatore C, Pandey K, Donnelly S, Pawate S, Bomprezzi R, et al. J Neurol Neurosurg Psychiatry. 2016 Feb 25. PMID: 26917698. Abstract CommentRecommendBookmarkWatch